Glover, M., Caplin, M., Leeuwenkamp, O. R., & Longworth, L. (2021). Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study. Elsevier.
Cita Chicago Style (17a ed.)Glover, Matthew, Martyn Caplin, Oscar R. Leeuwenkamp, y Louise Longworth. Use of [177Lu]Lu-DOTA-TATE in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: Results of a UK Cost-effectiveness Modelling Study. Elsevier, 2021.
Cita MLA (8a ed.)Glover, Matthew, et al. Use of [177Lu]Lu-DOTA-TATE in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: Results of a UK Cost-effectiveness Modelling Study. Elsevier, 2021.
Precaución: Estas citas no son 100% exactas.